210 related articles for article (PubMed ID: 24790385)
1. Results from 28 years of newborn screening for congenital adrenal hyperplasia in sapporo.
Morikawa S; Nakamura A; Fujikura K; Fukushi M; Hotsubo T; Miyata J; Ishizu K; Tajima T
Clin Pediatr Endocrinol; 2014 Apr; 23(2):35-43. PubMed ID: 24790385
[TBL] [Abstract][Full Text] [Related]
2. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants.
Güran T; Tezel B; Gürbüz F; Selver Eklioğlu B; Hatipoğlu N; Kara C; Şimşek E; Çizmecioğlu FM; Ozon A; Baş F; Aydın M; Darendeliler F
J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):13-23. PubMed ID: 30111524
[TBL] [Abstract][Full Text] [Related]
3. Twenty Years of Neonatal Screening for Congenital Adrenal Hyperplasia in North-Eastern Italy: Role of Liquid Chromatography-Tandem Mass Spectrometry as a Second-Tier Test.
Cavarzere P; Camilot M; Palma L; Lauriola S; Gaudino R; Vincenzi M; Antoniazzi F; Teofoli F; Piacentini G
Horm Res Paediatr; 2022; 95(3):255-263. PubMed ID: 35350013
[TBL] [Abstract][Full Text] [Related]
4. Newborn screening for congenital adrenal hyperplasia in Sapporo City: sixteen years experience.
Mikami A; Fukushi M; Oda H; Fujita K; Fujieda K
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():100-2. PubMed ID: 11400741
[TBL] [Abstract][Full Text] [Related]
5. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants.
Güran T; Tezel B; Çakır M; Akıncı A; Orbak Z; Keskin M; Selver Eklioğlu B; Ozon A; Özbek MN; Karagüzel G; Hatipoğlu N; Gürbüz F; Çizmecioğlu FM; Kara C; Şimşek E; Baş F; Aydın M; Darendeliler F
J Clin Res Pediatr Endocrinol; 2020 Sep; 12(3):287-294. PubMed ID: 32157855
[TBL] [Abstract][Full Text] [Related]
6. Neonatal Screening for Congenital Adrenal Hyperplasia in Denmark: 10 Years of Experience.
Lind-Holst M; Bækvad-Hansen M; Berglund A; Cohen AS; Melgaard L; Skogstrand K; Duno M; Main KM; Hougaard DM; Gravholt CH; Hansen D
Horm Res Paediatr; 2022; 95(1):35-42. PubMed ID: 35114680
[TBL] [Abstract][Full Text] [Related]
7. Neonatal mass screening for 21-hydroxylase deficiency.
Tajima T; Fukushi M
Clin Pediatr Endocrinol; 2016 Jan; 25(1):1-8. PubMed ID: 26865749
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
Liu SY; Lee CT; Tung YC; Chien YH; Hwu WL; Tsai WY
J Formos Med Assoc; 2018 Feb; 117(2):126-131. PubMed ID: 28392195
[TBL] [Abstract][Full Text] [Related]
9. Newborn screening for congenital adrenal hyperplasia in New York State.
Pearce M; DeMartino L; McMahon R; Hamel R; Maloney B; Stansfield DM; McGrath EC; Occhionero A; Gearhart A; Caggana M; Tavakoli NP
Mol Genet Metab Rep; 2016 Jun; 7():1-7. PubMed ID: 27331001
[TBL] [Abstract][Full Text] [Related]
10. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
Votava F; Török D; Kovács J; Möslinger D; Baumgartner-Parzer SM; Sólyom J; Pribilincová Z; Battelino T; Lebl J; Frisch H; Waldhauser F;
Eur J Endocrinol; 2005 Jun; 152(6):869-74. PubMed ID: 15941926
[TBL] [Abstract][Full Text] [Related]
11. Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment.
Carlson AD; Obeid JS; Kanellopoulou N; Wilson RC; New MI
J Steroid Biochem Mol Biol; 1999; 69(1-6):19-29. PubMed ID: 10418977
[TBL] [Abstract][Full Text] [Related]
12. Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
Zetterström RH; Karlsson L; Falhammar H; Lajic S; Nordenström A
Int J Neonatal Screen; 2020 Aug; 6(3):. PubMed ID: 33239597
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and diagnostic trends of congenital adrenal hyperplasia in Denmark: a retrospective, population-based study.
Berglund A; Ornstrup MJ; Lind-Holst M; Dunø M; Bækvad-Hansen M; Juul A; Borch L; Jørgensen N; Rasmussen ÅK; Andersen M; Main KM; Hansen D; Gravholt CH
Lancet Reg Health Eur; 2023 May; 28():100598. PubMed ID: 36891552
[TBL] [Abstract][Full Text] [Related]
14. A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing.
Gong LF; Gao X; Yang N; Zhao JQ; Yang HH; Kong YY
J Pediatr Endocrinol Metab; 2019 Mar; 32(3):253-258. PubMed ID: 30817302
[TBL] [Abstract][Full Text] [Related]
15. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
[TBL] [Abstract][Full Text] [Related]
16. Wisconsin's Screening Algorithm for the Identification of Newborns with Congenital Adrenal Hyperplasia.
Bialk ER; Lasarev MR; Held PK
Int J Neonatal Screen; 2019 Sep; 5(3):33. PubMed ID: 33072992
[TBL] [Abstract][Full Text] [Related]
17. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
[TBL] [Abstract][Full Text] [Related]
18. [Reevaluation of recalled infants by neonatal mass screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Diagnostic value of pregnanetriolone in a single urine specimen using glass capillary gas chromatography].
Hikita Y
Nihon Naibunpi Gakkai Zasshi; 1985 Mar; 61(3):197-219. PubMed ID: 3874793
[TBL] [Abstract][Full Text] [Related]
19. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in croatia between 1995 and 2006.
Dumic K; Krnic N; Skrabic V; Stipancic G; Cvijovic K; Kusec V; Stingl K
Horm Res; 2009; 72(5):310-4. PubMed ID: 19844117
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
